StockData
BioHarvest Sciences Inc. logo

BioHarvest Sciences Inc. (BHST) stock

BHSTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 40-F on Mar 31, 2026Score 5/30
$1.30−0.02 (-1.52%)

Close on Nov 20, 2026Market cap $29.47MP/E –Yield –

BioHarvest Sciences free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

For fiscal 2025 it was -$9.58M.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$9.58M–
FY2024Dec 31, 2024-$9.52M–
FY2023Dec 31, 2023-$10.00M–

More BioHarvest Sciences figures

See a number that looks wrong?